BIOPHARMA AND THE MANAGEMENT OF WALL ST. DURING A PANDEMIC
Biopharma And The Management Of Wall St. During A Pandemic
The volatility of the U.S. stock market in the first half of 2020 has even the heartiest investor queasy. But how about the leaders of such publicly traded companies? We conduct a virtual roundtable with three CEOs of publicly traded biopharmaceutical companies to learn how they are leading their organizations while also managing the expectations of Wall Street during the COVID-19 pandemic.
LEADERSHIP DURING COVID-19 — A BIOPHARMA CEO ROUNDTABLE
Leadership During COVID-19 — A Biopharma CEO Roundtable
Five biopharmaceutical industry CEOs discuss challenges their company's have faced, along with best practices implemented in managing through the COVID-19 chaos.
During the COVID-19 pandemic of 2020, Life Science Leader decided to engage with some of our executive-level readers via Zoom conference calls. These virtual roundtables were hosted by our Chief Editor Rob Wright and then broken up into shorter clips based on specific questions or topics discussed during the full-length call.